Gyre Therapeutics (GYRE) EBT Margin (2010 - 2026)
Gyre Therapeutics (GYRE) recorded EBT Margin of -49.59% in Q2 2026, down 44.30 percentage points from -5.30% a year earlier and down 8.57 percentage points from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) EBT Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Gyre Therapeutics' EBT Margin came in at -13.49% as of Jun 30, 2026, down 20.87 percentage points year-over-year; for FY2025, it was 12.38%, down 9.57 percentage points from FY2024.
- Annual EBT Margin has a five-year change of +280.86 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at 21.95% in FY2024 (+89.79 pp), -67.84% in FY2023 (-77.04 pp), 9.20% in FY2022 (+1207.53 pp) and -1198.32% in FY2021 (-929.84 pp).
- The Q2 2026 figure is the lowest quarterly EBT Margin since Q4 2023.
- On a year-over-year basis, EBT Margin has declined for three consecutive quarters, with an average year-over-year change of +24.85 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 1855.88 percentage points in Q1 2023, against a drop of 346.91 percentage points in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -41.02% (Q1 2026), -0.18% (Q4 2025) and 24.96% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | -49.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -49.59% |
| Mar 31, 2026 | -41.02% |
| Dec 31, 2025 | -0.18% |
| Sep 30, 2025 | 24.96% |
| Jun 30, 2025 | -5.30% |
| Mar 31, 2025 | 21.01% |
| Dec 31, 2024 | 2.77% |
| Sep 30, 2024 | 15.42% |
| Jun 30, 2024 | 23.92% |
| Mar 31, 2024 | 45.93% |
| Dec 31, 2023 | -369.38% |
| Sep 30, 2023 | 34.92% |
| Jun 30, 2023 | 19.96% |
| Mar 31, 2023 | 25.15% |
| Dec 31, 2022 | -22.46% |
| Mar 31, 2022 | -1,830.73% |
| Dec 31, 2021 | -833.16% |
| Sep 30, 2021 | -1,097.78% |
| Jun 30, 2021 | -1,760.42% |
| Mar 31, 2021 | -1,529.52% |
API Access
Gyre Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();